Genetically modulating T-cell function to target cancer.
about
Trial Watch: Adoptive cell transfer for oncological indicationsImmunotherapy for colorectal cancerHow (specific) would like your T-cells today? Generating T-cell therapeutic function through TCR-gene transferAn NCR1-based chimeric receptor endows T-cells with multiple anti-tumor specificities.Classification of current anticancer immunotherapiesIn-vitro Optimization of Nanoparticle-Cell Labeling Protocols for In-vivo Cell Tracking ApplicationsTrial Watch: Adoptive cell transfer for anticancer immunotherapy."Model t" cells: a time-tested vehicle for gene therapy2D TCR-pMHC-CD8 kinetics determines T-cell responses in a self-antigen-specific TCR system.Gold nanoparticles for in vivo cell tracking.Out of the bitter came forth sweet: Activating CD28-dependent co-stimulation via PD-1 ligands.Messenger RNA encoding constitutively active Toll-like receptor 4 enhances effector functions of human T cells.Selective immunotargeting of diabetogenic CD4 T cells by genetically redirected T cells.Single-cell T-cell receptor-β analysis of HLA-A*2402-restricted CMV- pp65-specific cytotoxic T-cells in allogeneic hematopoietic SCT.Functional differences between low- and high-affinity CD8(+) T cells in the tumor environment.Trial Watch: Adoptive cell transfer for anticancer immunotherapy.Enhanced antitumor activity mediated by human 4-1BB-engineered T cells.Targeting Multiple Tumors Using T-Cells Engineered to Express a Natural Cytotoxicity Receptor 2-Based Chimeric Receptor.Retrospective study of the prognostic significance of neutrophil-to-lymphocyte ratio for postsurgical outcomes of patients with endometrial carcinoma.
P2860
Q26785545-6D0E7B01-CAB7-4CF8-BDD9-C34B7B69EA6FQ27021837-49E6608E-4A3E-41D9-9641-596D7C953917Q28727481-7F90D7F7-1EDD-426B-A4AE-A3CBCFC459E8Q34786615-CF005B59-3A00-43FE-96D5-245971EF80C8Q35149637-C314FF10-2878-4B14-BBE9-8D5239E7ED2BQ36216873-13628A08-97B4-485C-A193-99A92F431977Q36887833-4C6397E3-34DA-488F-99F6-99B9D8C022B5Q37201423-D9F5153A-B01E-48E4-A220-DA0C053103C7Q37614812-13694FCB-2250-41AF-9769-2E9535EA969FQ38262550-5B126B53-8C2C-4F64-83B0-A15EBC7B3B29Q38627207-16CE9EBB-5A64-4095-A884-B276F5FC4216Q38849182-D8330409-684B-4400-AF32-BD8361982BD0Q38983184-4CF2AE74-BA2E-4993-BAA7-93D08BB0A7D5Q42277578-D0F794CA-CFB0-4D8F-BD97-95707439847AQ42403156-ABAD8E80-851D-42BB-B0B3-5622FD1C0434Q42702234-E0EE46D5-B417-4091-BBC6-834AE3D8A74DQ45441936-898699A5-F0CF-4605-A700-E2E8BBF4A7B7Q47111488-15D7252A-D367-4C65-8399-3301A7C89250Q47350448-5C402682-B51E-4B71-AEC5-01F3249D6563
P2860
Genetically modulating T-cell function to target cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Genetically modulating T-cell function to target cancer.
@en
Genetically modulating T-cell function to target cancer.
@nl
type
label
Genetically modulating T-cell function to target cancer.
@en
Genetically modulating T-cell function to target cancer.
@nl
prefLabel
Genetically modulating T-cell function to target cancer.
@en
Genetically modulating T-cell function to target cancer.
@nl
P1476
Genetically modulating T-cell function to target cancer
@en
P2093
Astar Haga-Friedman
Efrat Merhavi-Shoham
P356
10.1016/J.SEMCANCER.2011.12.006
P50
P577
2011-12-24T00:00:00Z